VHT:ARCA-Vanguard Health Care ETF - DNQ

ETF | Health | NYSE Arca

Last Closing Price

USD 169.03

Change

0.00 (0.00)%

Market Cap

USD 8.82B

Volume

0.26M

Average Target Price

N/A
Average Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

Inception Date: 26/01/2004

Primary Benchmark: MSCI US IMI/Health Care 25-50 GR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.1%

Management Expense Ratio: 0.10 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-12-09 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

N/A

USD 19.01B
XBI SPDR Series Trust S&P Biotech 0.35 %

N/A

USD 4.06B
IHI iShares U.S. Medical Devices 0.43 %

N/A

USD 2.92B
FBT First Trust Amex Biotech Index.. 0.56 %

N/A

USD 2.64B
IYH iShares U.S. Healthcare 0.43 %

N/A

USD 2.45B
FXH First Trust Health Care AlphaD.. 0.62 %

N/A

USD 2.27B
IXJ iShares Global Healthcare 0.47 %

N/A

USD 1.74B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

N/A

USD 1.61B
IHF iShares U.S. Health Care Provi.. 0.43 %

N/A

USD 1.16B
HQH Tekla Healthcare Investors 0.00 %

N/A

USD 0.84B

ETFs Containing VHT

LDRS Innovator IBD ETF Leaders 4.12 % 0.00 %

N/A

USD 0.03B

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.66% 71% C- 89% B+
Dividend Return 1.04% 64% D 19% F
Total Return 10.70% 71% C- 88% B+
Trailing 12 Months  
Capital Gain 9.32% 71% C- 89% B+
Dividend Return 1.40% 62% D- 22% F
Total Return 10.72% 75% C 87% B+
Trailing 5 Years  
Capital Gain 66.66% 71% C- 88% B+
Dividend Return 9.37% 70% C- 30% F
Total Return 76.03% 76% C 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 10.95% 79% C+ 80% B-
Dividend Return 12.40% 79% C+ 79% C+
Total Return 1.45% 59% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 11.40% 68% D+ 62% D-
Risk Adjusted Return 108.79% 86% B 86% B
Market Capitalization 5.43B 96% A 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:

There is nothing we particularly dislike